Back to search
Pre-Exposure Prophylaxis (PrEP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-Exposure Prophylaxis (PrEP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-Exposure Prophylaxis (PrEP) trials you may qualify forThe primary purpose of this study is to assess the safety of long-acting injectable cabotegravir (CAB-LA) and oral pre-expose prophylaxis (PrEP) (FTC/TDF or 3TC…
The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) a…
This study aims to learn more about anal cancer risk in men who have sex with men (MSM) who are using Pre-Exposure Prophylaxis (PrEP) to prevent HIV. Specifical…
The goal of this clinical trial is to see if an injectable medicine called naltrexone can prevent fentanyl overdose deaths in people who use other drugs (cocain…
This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
The goal of this study is to learn if STEP-UP (Streamlining Telehealth for Expanded PrEP Utilization through community Partnerships) works to expand access to P…
The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exp…
The PrEP SMART study is testing a stepped model of scalable adherence support strategies in South African young women who initiate PrEP using a SMART (sequentia…